We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+0.68%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.14B
AUM Growth
+$151M
Cap. Flow
+$206M
Cap. Flow %
9.63%
Top 10 Hldgs %
24.8%
Holding
4,288
New
194
Increased
2,613
Reduced
979
Closed
178

Sector Composition

Rank Sector Weight
1 Technology 25.58%
2 Financials 11.73%
3 Industrials 9.24%
4 Healthcare 8.47%
5 Consumer Discretionary 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSV icon
3351
Vanguard Short-Term Bond ETF
BSV
$45.6B
$1.25K ﹤0.01%
16
+2
+14% +$157
WNEB icon
3352
Western New England Bancorp
WNEB
$275M
$1.25K ﹤0.01%
97
+35
+56% +$459
AQST icon
3353
Aquestive Therapeutics
AQST
$494M
$1.24K ﹤0.01%
299
+107
+56% +$434
MFIN icon
3354
Medallion Financial
MFIN
$250M
$1.24K ﹤0.01%
+145
New +$1.43K
SRI icon
3355
Stoneridge
SRI
$213M
$1.24K ﹤0.01%
257
-32
-11% -$219
BYRN icon
3356
Byrna Technologies
BYRN
$101M
$1.24K ﹤0.01%
135
-60
-31% -$787
CARL
3357
Carlsmed
CARL
$377M
$1.22K ﹤0.01%
+135
New +$1.63K
CADL icon
3358
Candel Therapeutics
CADL
$776M
$1.22K ﹤0.01%
249
-46
-16% -$250
INNV icon
3359
InnovAge Holding
INNV
$1.52B
$1.21K ﹤0.01%
151
+24
+19% +$179
SPAB icon
3360
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.94B
$1.2K ﹤0.01%
47
ACHL
3361
DELISTED
Achilles Therapeutics
ACHL
$1.19K ﹤0.01%
806
IMMR icon
3362
Immersion
IMMR
$252M
$1.19K ﹤0.01%
218
+56
+35% +$353
HNVR icon
3363
Hanover Bancorp
HNVR
$198M
$1.19K ﹤0.01%
55
+22
+67% +$490
CMPX icon
3364
Compass Therapeutics
CMPX
$387M
$1.19K ﹤0.01%
224
+195
+672% +$1.13K
VWOB icon
3365
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.25B
$1.18K ﹤0.01%
18
-26
-59% -$1.75K
DOMO icon
3366
Domo
DOMO
$184M
$1.18K ﹤0.01%
386
+14
+4% +$71
LOCO icon
3367
El Pollo Loco
LOCO
$462M
$1.18K ﹤0.01%
85
-245
-74% -$2.81K
PEBK icon
3368
Peoples Bancorp of North Carolina
PEBK
$229M
$1.18K ﹤0.01%
30
+2
+7% +$75
AVXL icon
3369
Anavex Life Sciences
AVXL
$310M
$1.17K ﹤0.01%
380
-64
-14% -$277
CSTL icon
3370
Castle Biosciences
CSTL
$979M
$1.13K ﹤0.01%
46
-6
-12% -$197
MVST icon
3371
Microvast
MVST
$302M
$1.12K ﹤0.01%
749
-999
-57% -$2.41K
TRVI icon
3372
Trevi Therapeutics
TRVI
$2.64B
$1.12K ﹤0.01%
94
-86
-48% -$963
NATH icon
3373
Nathan's Famous
NATH
$402M
$1.11K ﹤0.01%
11
+2
+22% +$198
BLND icon
3374
Blend Labs
BLND
$386M
$1.1K ﹤0.01%
648
-373
-37% -$797
CD
3375
Chaince Digital Holdings
CD
$211M
$1.1K ﹤0.01%
277
+141
+104% +$724

Similar funds

GAMMA Investing's Q1 2026 Portfolio in Review

As of Q1 2026, GAMMA Investing held 4,288 positions worth $2.14B, up 7.6% from $1.99B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

GAMMA Investing deployed $206M of net new capital in Q1 2026, opening 194 new positions and adding to 2,613 existing holdings. Its largest new stake was State Street US Sector Rotation ETF: 3,589 shares worth $207K.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $834K trimmed.

  • GAMMA Investing's largest Q1 2026 buy was State Street US Sector Rotation ETF: 3,589 shares worth $207K.
  • GAMMA Investing added most to NVIDIA in Q1 2026, an estimated $6.6M increase.
  • GAMMA Investing's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $834K.
  • GAMMA Investing fully exited Comerica in Q1 2026, selling an estimated $581K.
  • GAMMA Investing's ten largest holdings make up 25% of its $2.14B portfolio in Q1 2026.
  • GAMMA Investing opened 194 new positions and closed 178 in Q1 2026.
  • GAMMA Investing's portfolio value rose 7.6% quarter-over-quarter to $2.14B.

Based on GAMMA Investing's 13F filing for Q1 2026, filed 6 Apr 2026.